Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu Liu (Amy), Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas, Samuel Kadoury, Alexandra Rink, Srinivas Raman, Aravindhan Sundaramurthy, Robert Weersink, Dominic Béliveau-Nadeau, Joelle Helou and Peter Chun
Article (2022)
An external link is available for this itemDepartment: | Department of Computer Engineering and Software Engineering |
---|---|
PolyPublie URL: | https://publications.polymtl.ca/51917/ |
Journal Title: | Frontiers in Oncology (vol. 12) |
Publisher: | Frontiers media sa |
DOI: | 10.3389/fonc.2022.971344 |
Official URL: | https://doi.org/10.3389/fonc.2022.971344 |
Date Deposited: | 18 Apr 2023 14:59 |
Last Modified: | 25 Sep 2024 16:42 |
Cite in APA 7: | Ménard, C., Navarro-Domenech, I., Liu, Z., Joseph, L., Barkati, M., Berlin, A., Delouya, G., Taussky, D., Beauchemin, M.-C., Nicolas, B., Kadoury, S., Rink, A., Raman, S., Sundaramurthy, A., Weersink, R., Béliveau-Nadeau, D., Helou, J., & Chun, P. (2022). MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer. Frontiers in Oncology, 12, 971344 (9 pages). https://doi.org/10.3389/fonc.2022.971344 |
---|---|
Statistics
Dimensions